4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide

C93H89F7N18O5 — CID 158920192

IUPAC4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide
SMILESCc1cn(C2CCN(Cc3ccc4c(-c5ccc(F)cc5)cc(C(N)=O)nc4c3)CC2)cn1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCCC(n4cncn4)C3)cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCNCC3)cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCOC(C(F)(F)F)C3)cc2n1
InChIInChI=1S/C26H26FN5O.C24H23FN6O.C22H19F4N3O2.C21H21FN4O/c1-17-14-32(16-29-17)21-8-10-31(11-9-21)15-18-2-7-22-23(19-3-5-20(27)6-4-19)13-25(26(28)33)30-24(22)12-18;25-18-6-4-17(5-7-18)21-11-23(24(26)32)29-22-10-16(3-8-20(21)22)12-30-9-1-2-19(13-30)31-15-27-14-28-31;23-15-4-2-14(3-5-15)17-10-19(21(27)30)28-18-9-13(1-6-16(17)18)11-29-7-8-31-20(12-29)22(24,25)26;22-16-4-2-15(3-5-16)18-12-20(21(23)27)25-19-11-14(1-6-17(18)19)13-26-9-7-24-8-10-26/h2-7,12-14,16,21H,8-11,15H2,1H3,(H2,28,33);3-8,10-11,14-15,19H,1-2,9,12-13H2,(H2,26,32);1-6,9-10,20H,7-8,11-12H2,(H2,27,30);1-6,11-12,24H,7-10,13H2,(H2,23,27)
InChIKeyJHSWVAQAOOBSIB-UHFFFAOYSA-N
MW1671.84 g/mol
LogP14.50
Rot. Bonds18

About 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide

4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide (PubChem CID 158920192) has the molecular formula C93H89F7N18O5 and a molecular weight of 1671.84 g/mol. Its IUPAC name is 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide.

Molecular Properties

Compound Name4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide
PubChem CID158920192
Molecular FormulaC93H89F7N18O5
Molecular Weight1671.84 g/mol
Exact Mass1670.72
IUPAC Name4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide
SMILESCc1cn(C2CCN(Cc3ccc4c(-c5ccc(F)cc5)cc(C(N)=O)nc4c3)CC2)cn1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCCC(n4cncn4)C3)cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCNCC3)cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCOC(C(F)(F)F)C3)cc2n1
InChIInChI=1S/C26H26FN5O.C24H23FN6O.C22H19F4N3O2.C21H21FN4O/c1-17-14-32(16-29-17)21-8-10-31(11-9-21)15-18-2-7-22-23(19-3-5-20(27)6-4-19)13-25(26(28)33)30-24(22)12-18;25-18-6-4-17(5-7-18)21-11-23(24(26)32)29-22-10-16(3-8-20(21)22)12-30-9-1-2-19(13-30)31-15-27-14-28-31;23-15-4-2-14(3-5-15)17-10-19(21(27)30)28-18-9-13(1-6-16(17)18)11-29-7-8-31-20(12-29)22(24,25)26;22-16-4-2-15(3-5-16)18-12-20(21(23)27)25-19-11-14(1-6-17(18)19)13-26-9-7-24-8-10-26/h2-7,12-14,16,21H,8-11,15H2,1H3,(H2,28,33);3-8,10-11,14-15,19H,1-2,9,12-13H2,(H2,26,32);1-6,9-10,20H,7-8,11-12H2,(H2,27,30);1-6,11-12,24H,7-10,13H2,(H2,23,27)
InChIKeyJHSWVAQAOOBSIB-UHFFFAOYSA-N
XLogP14.50
TPSA306.67 Ų
H-Bond Donors5
H-Bond Acceptors19
Rotatable Bonds18
Heavy Atoms123
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001671.84
LogP ≤ 514.50
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1019

Analyze 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide?
The IUPAC name of 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide (CID 158920192) is 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide.
What is the SMILES notation for 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide?
The canonical SMILES for 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide is Cc1cn(C2CCN(Cc3ccc4c(-c5ccc(F)cc5)cc(C(N)=O)nc4c3)CC2)cn1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCCC(n4cncn4)C3)cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCNCC3)cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2ccc(CN3CCOC(C(F)(F)F)C3)cc2n1.
What is the InChIKey of 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide?
The InChIKey is JHSWVAQAOOBSIB-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26FN5O.C24H23FN6O.C22H19F4N3O2.C21H21FN4O/c1-17-14-32(16-29-17)21-8-10-31(11-9-21)15-18-2-7-22-23(19-3-5-20(27)6-4-19)13-25(26(28)33)30-24(22)12-18;25-18-6-4-17(5-7-18)21-11-23(24(26)32)29-22-10-16(3-8-20(21)22)12-30-9-1-2-19(13-30)31-15-27-14-28-31;23-15-4-2-14(3-5-15)17-10-19(21(27)30)28-18-9-13(1-6-16(17)18)11-29-7-8-31-20(12-29)22(24,25)26;22-16-4-2-15(3-5-16)18-12-20(21(23)27)25-19-11-14(1-6-17(18)19)13-26-9-7-24-8-10-26/h2-7,12-14,16,21H,8-11,15H2,1H3,(H2,28,33);3-8,10-11,14-15,19H,1-2,9,12-13H2,(H2,26,32);1-6,9-10,20H,7-8,11-12H2,(H2,27,30);1-6,11-12,24H,7-10,13H2,(H2,23,27).
What are the key properties of 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide?
4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide has a molecular weight of 1671.84 g/mol, XLogP of 14.50, 18 rotatable bonds, 5 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(4-fluorophenyl)-7-[[4-(4-methylimidazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-(piperazin-1-ylmethyl)quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[3-(1,2,4-triazol-1-yl)piperidin-1-yl]methyl]quinoline-2-carboxamide;4-(4-fluorophenyl)-7-[[2-(trifluoromethyl)morpholin-4-yl]methyl]quinoline-2-carboxamide is sourced from PubChem (CID 158920192), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).